Altre lingue CollPlant Biotechnologies Ltd.

Azioni

CLGN

IL0004960188

Mercato chiuso - Nasdaq Altri mercati azionari 22:30:00 11/07/2024			Variaz. 5gg	Var. 1 gen.
5,1 ^USD	0,00%		+2,00%	-20,19%

06/06	Collplant stampa con successo protesi mammarie rigenerative di dimensioni commerciali da 200 cc e riporta ulteriori dati preclinici positivi.	CI
29/05	CollPlant Biotechnologies Ltd. Riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Collplant Successfully Bio-Prints 200Cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical Data	06/06
Earnings Flash (CLGN) COLLPLANT Reports Q1 Revenue $98,000, vs. Street Est of $650,000	29/05
CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update	29/05
CollPlant Biotechnologies Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/05
COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE	04/04
COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE	04/04
CollPlant Biotechnologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04/04
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION	26/03
CollPlant Issues Letter to Shareholders	15/02
CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants	02/01
CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants	02/01
Earnings Flash (CLGN) COLLPLANT Posts Q3 Revenue $43,000	29/11
CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023	29/11
CollPlant Biotechnologies Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29/11
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION	09/11
CollPlant Biotechnologies Issued US Patent for Photocurable Dermal Filler	01/11
CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler	01/11
Wall Street Set to Open Slightly Higher; Weekly Jobless Claims Fall to Near Historic Lows	19/10/23
Top Premarket Decliners	19/10/23
CollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability Initiative	21/09/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue CollPlant Biotechnologies Ltd.

Azioni

CLGN

IL0004960188

Altre lingue

Filtri